| 0901 | | Coffee, whether or not roasted or decaffeinated; coffee husks and skins; coffee substitutes containing coffee in any proportion: | | | | |
| 0901.11.00 | | Not decaffeinated | | Free | | Free |
| 0901.12.00 | 00 | Decaffeinated | kg | Free | | Free |
| 0901.21.00 | | Not decaffeinated | | Free | | Free |
| 0901.22.00 | | Decaffeinated | | Free | | Free |
| 0910 | | Ginger, saffron, turmeric (curcuma), thyme, bay leaves, curry and other spices: | | | | |
| 0910.20.00 | 00 | Saffron | kg | Free | | Free |
| 1401 | | Vegetable materials of a kind used primarily for plaiting (for example, bamboos, rattans, reeds, rushes, osier, raffia, cleaned, bleached or dyed cereal straw, and lime bark): | | | | |
| 1512 | | Sunflower-seed, safflower or cottonseed oil, and fractions thereof, whether or not refined, but not chemically modified: | | | | |
| 1512.11.00 | | Sunflower-seed or safflower oil and fractions thereof: | | | | |
| 1512.11.00 | 40 | Safflower oil | kg | | | |
| 1512.19.00 | 40 | Safflower oil | kg | | | |
| 1905.31.00 | | Sweet biscuits; waffles and wafers: | | | | |
| 1905.32.00 | | Waffles and wafers | | Free | | 30% |
| 2101.11.21 | 31 | Decaffeinated: | | | | |
| 2101.11.21 | 26 | Not decaffeinated: | | | | |
| 2308.00.93 | 00 | Screenings, scalpings, chaff or scourings, ground, or not ground, of flaxseed (linseed) | kg | Free | | 10% |
| 2712 | | Petroleum jelly; paraffin wax, microcrystalline petroleum wax, slack wax, ozokerite, lignite wax, peat wax, other mineral waxes and similar products obtained by synthesis or by other processes, whether or not colored: | | | | |
| 2712.20.00 | 00 | Paraffin wax containing by weight less than 0.75 percent of oil | kg | Free | | 2.2￠/kg |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2939.30.00 | 00 | Caffeine and its salts | kg | Free | | 59% |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.90.91 | 65 | Preparations primarily affecting the electrolytic, caloric or water balance: | | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
